New Jersey-based Eagle Pharmaceuticals, a company geared towards pharmaceutical hospital sales, finalized terms to acquire Acacia Pharma.

Cosette Pharmaceuticals Inc., a New Jersey-based pharmaceutical company, announced the launch of Prochlorperazine Edisylate injection, 10 mg/2ml (5mg/ml).

Shares of Acacia Pharma skyrocketed in trading after the company announced FDA approval for Barhemsys (amisulpride injection) for the prevention and treatment of postoperative nausea and vomiting (PONV) in adults.